covid 19 News and Research

RSS

Sustained immune response memory detected in recovered COVID-19 patients

A team of researchers at the University of Washington School of Medicine has found that people who had mild COVID-19 developed a multi-layered immune response against SARS-Cov-2. The researchers detected neutralizing antibodies against the virus for at least three months after recovering from the infection.

11 Jan 2021

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

A recent study has found that extracellular vimentin can bind to SARS-CoV-2 spike protein in vitro, and antibodies against vimentin can decrease virus infectivity by up to 80%. This suggests vimentin could aid the virus’s binding to host cells and help in infection.

11 Jan 2021

KAIST develops low-cost and ready-for-rapid-production negative pressure room

A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM).

11 Jan 2021

Researchers succeed in mapping the structure of virus that causes diarrhea

Researchers at Umeå University in Sweden have for the first time at the atomic level succeeded in mapping what a virus looks like that causes diarrhea and annually kills about 50,000 children in the world.

11 Jan 2021

Could Ivermectin be an effective antiviral against SARS-CoV-2?

A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.

11 Jan 2021

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

Scientists from Germany and China recently conducted a large meta-analysis using transcriptome data of SARS-CoV-2 to evaluate the routes of viral entry and the characteristics of innate immune responses induced by SARS-CoV-2 infection.

11 Jan 2021

How effective are masks in preventing SARS-CoV-2 transmission?

Can face masks protect against SARS-CoV-2 infection? Faruque Ahmad, MD, recently explored the role of face masks in mitigating the coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2.

11 Jan 2021

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

As asymptomatic transmission chains play a role in SARS-CoV-2’s viral spread, a new study by researchers in Wuhan, China, investigated the seroprevalence and asymptomatic carrier status of SARS-CoV-2 in the region.

11 Jan 2021

Researchers reach important milestone in leishmaniasis vaccine development

Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

11 Jan 2021

New agent-based model can be used for making informed choices regarding COVID-19 restrictions

What happens when municipalities in the Copenhagen area experience a COVID-19 flare-up? Would closing the schools have any effect, or would a better choice be directing the parents to work from home? Due to the COVID-19 pandemic, authorities worldwide have several times implemented steps to keep the pandemic in check.

11 Jan 2021

‘Peer respites’ provide an alternative to psychiatric wards during pandemic

Mia McDermott is no stranger to isolation. Abandoned as an infant in China, she lived in an orphanage until a family in California adopted her as a toddler.

11 Jan 2021

One ambulance ride leads to another when packed hospitals cannot handle non-covid patients

Keely Connolly thought she would be safe once the ambulance arrived at Hutchinson Regional Medical Center in Kansas.

11 Jan 2021

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

As the rollout of covid-19 vaccines picks up across the U.S., moving from hospital distribution to pharmacies, pop-up sites and drive-thru clinics, health experts say it's vital that these expanded venues be prepared to handle rare but potentially life-threatening allergic reactions.

11 Jan 2021

Anti-Black racism in Canada’s health care impacts people’ health, argue experts

Canada must dismantle anti-Black racism in health care to address its harmful effects on people's health, argue authors of a commentary in CMAJ (Canadian Medical Association Journal)

11 Jan 2021

Schlieren techniques demonstrate patterns of exhaled air spread from wind instruments and singers

In an interesting new research paper published recently on the bioRxiv preprint server, scientists describe the dispersal of exhaled air, potentially infected, from singers and those playing wind instruments, using Schlieren techniques, a visual process that is used to photograph the flow of fluids of varying density. This could help assess measures to assess the actual spread of infectious droplets or aerosols in such situations.

10 Jan 2021

Tetherin downregulation by SARS-CoV-2 enhances viral spread

A new preprint research paper published on the bioRxiv server describes the role of a host protein called tetherin in the spread of the novel coronavirus.

10 Jan 2021

Synthetic lung organoids provide high-throughput platform to identify new cellular targets of SARS-CoV-2

An interesting new study published on the bioRxiv preprint server describes a new platform that allows a high-throughput workflow to generate matched human lung buds in the tens of thousands. This allows researchers to study SARS-CoV-2 infection and therapeutics in lung tissue that mirrors the key aspects of human lung development.

10 Jan 2021

Large-scale genome sequencing shows how SARS-CoV-2 mutated

A new study published on the preprint server bioRxiv* describes the results of genomic sequencing of the virus, which may help trace the routes of transmission of the virus from person to person, and from country to country.

10 Jan 2021

Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences

In a recent bioRxiv preprint study, researchers from the University of Hawaii showed that the S gene of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously mutating according to the sequence and phylogenetic analysis.

10 Jan 2021

Researchers pinpoint spike protein regions as targets for passive and active COVID-19 vaccines

Researchers at Stanford University School of Medicine have identified regions of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have relatively few mutations and might therefore serve as important targets for prophylactic agents against coronavirus disease 2019 (COVID-19).

10 Jan 2021

covid 19 News and Research

Sustained immune response memory detected in recovered COVID-19 patients

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

KAIST develops low-cost and ready-for-rapid-production negative pressure room

Researchers succeed in mapping the structure of virus that causes diarrhea

Could Ivermectin be an effective antiviral against SARS-CoV-2?

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

How effective are masks in preventing SARS-CoV-2 transmission?

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

Researchers reach important milestone in leishmaniasis vaccine development

New agent-based model can be used for making informed choices regarding COVID-19 restrictions

‘Peer respites’ provide an alternative to psychiatric wards during pandemic

One ambulance ride leads to another when packed hospitals cannot handle non-covid patients

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Anti-Black racism in Canada’s health care impacts people’ health, argue experts

Schlieren techniques demonstrate patterns of exhaled air spread from wind instruments and singers

Tetherin downregulation by SARS-CoV-2 enhances viral spread

Synthetic lung organoids provide high-throughput platform to identify new cellular targets of SARS-CoV-2

Large-scale genome sequencing shows how SARS-CoV-2 mutated

Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences

Researchers pinpoint spike protein regions as targets for passive and active COVID-19 vaccines

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News